课题基金 / 基金详情

Understanding the beneficial role of glucagon-like peptide-1 (GLP-1) for normalizing intestinal lipoprotein metabolism during insulin resistance

Understanding the beneficial role of glucagon-like peptide-1 (GLP-1) for normalizing intestinal lipoprotein metabolism during insulin resistance
了解胰高血糖素样肽 1 (GLP-1) 在胰岛素抵抗期间使肠道脂蛋白代谢正常化的有益作用
批准号：
255025
负责人：
Farr Sarah L
金额：
$1.27万
依托单位：
Hospital for Sick Children (Toronto)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-02-01 至 2013-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=255025&lang=en
关键词：
Apob48 Chylomicron Collection Dpp-Iv Inhibitor Dyslipidemia Glucagon-Like Peptide-1 Intracerebroventricular Injection Postprandial Lipoproteins Small Intestine Syrian Golden Hamster Model Type 2 Diabetes

项目摘要

项目成果

Farr Sarah L的其他基金

相关文献

中文摘要
翻译
2型糖尿病已经被贴上了世界性流行病的标签，目前有2.85亿人受到影响；预计到2030年，这一数字将达到4.39亿。虽然这种情况是众所周知的会导致高血糖水平，但在
英文摘要
Type 2 diabetes has been labelled a world-wide epidemic, with 285 million individuals currently affected; a number that is expected to reach 439 million by the year 2030. Though this condition is known for causing high blood sugar levels, abnormalities in
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bile acid signaling as a novel regulator of postprandial lipemia and intestinal lipoprotein production
Understanding the beneficial role of glucagon-like peptide-1 (GLP-1) for normalizing intestinal lipoprotein metabolism during insulin resistance
  • 批准号：
    283892
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $7.65万
  • 财政年份：
    2012
  • 负责人：
    Farr Sarah L
  • 依托单位：
    Hospital for Sick Children (Toronto)